PRODUCTS

Online Inquiry

For Research Use Only. Not For Clinical Use.

STEMOD™ iPSC-derived PD Model (Parkin (PRAK2), V324A)(MoCNS-WQ013)

Datasheet

Parkinson disease is a slowly progressive neurodegenerative disorder characterized by bradykinesia, rigidity, resting tremor, postural instability, neuronal loss in the substantia nigra, and the presence of neurofibrillary MAPT (tau)-positive and Lewy bodies in some patients. This disease cell model has a V324A mutation in Parkin gene. it belongs to autosomal recessive juvenile Parkinson's disease (PARK2). Generating pluripotent stem cells from fibroblasts, then differentiate into neurons . This disease cell model provides a platform to explore disease mechanisms in PD.

Specifications
Organ System Central Nervous System
Disease Parkinson Disease (PD)
Target Gene Parkin (PRAK2)
Gene Function It encodes a component of an E3 ubiquitin ligase involved in mitochondrial homeostasis
Mutation V324A
Phenotype Exhibited abnormal mitochondrial morphology and impaired mitochondrial homeostasis.
Source Fibroblasts
Cellular Assays Immunocytochemistr, Electrophysiology, Electron Microscopy, Western Blotting
Target Gene
Gene ID 5071
Uniprot ID O60260

For Research Use Only. Not For Clinical Use.

Related Products